Literature DB >> 9286754

Macrophage colony stimulating factor down-regulates MCSF-receptor expression and entry of progenitors into the osteoclast lineage.

X Fan1, D M Biskobing, D Fan, W Hofstetter, J Rubin.   

Abstract

Macrophage colony-stimulating factor (MCSF), although necessary for entry of precursors into the early preosteoclast pathway, inhibits osteoclastogenesis at high doses. To clarify the relationship between MCSF and osteoclast formation, we investigated the effect of exogenous MCSF in murine bone marrow culture. Precursor proliferation and the expression of MCSF-receptor were examined after 4 days of culture in the presence or absence of accessory stromal cells. In both mixed marrow and destromalized cell cultures, exogenous MCSF dose-dependently decreased 125I-MCSF binding (by 65 +/- 5.0% at 3500 and 87 +/- 16.7% at-7000 U/ml, respectively) while enhancing mononuclear cell proliferation after 3 days of exposure (by 2.8- and 6.3-fold, respectively). These effects were maintained 24 h after removal of exogenous MCSF and, as such, likely represented an MCSF-induced change in MCSF receptor-bearing cells. Exposure to exogenous MCSF (3500 U/ml) days 2-4 dose-dependently inhibited tartrate resistant acid phosphatase positive multinuclear cell (TRAP+ MNC) formation counted at the end of day 7, by 64.3 +/- 4.1%. This inhibition of TRAP+ MNC formation was preceded by a 92 +/- 9% decrease in the expression of carbonic anhydrase II mRNA measurable at 4 days. These results indicate that MCSF promotes proliferation of a population of cells expressing lower cognate receptor sites. Changes in MCSF-receptor expression appear to modulate the final lineage selection of the pluripotent monoblastic progenitor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286754     DOI: 10.1359/jbmr.1997.12.9.1387

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

Review 1.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 2.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

3.  The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells.

Authors:  Jill Rahnert; Xian Fan; Natasha Case; Tamara C Murphy; Francesco Grassi; Buer Sen; Janet Rubin
Journal:  Bone       Date:  2008-03-20       Impact factor: 4.398

4.  Intranuclear Actin Regulates Osteogenesis.

Authors:  Buer Sen; Zhihui Xie; Gunes Uzer; William R Thompson; Maya Styner; Xin Wu; Janet Rubin
Journal:  Stem Cells       Date:  2015-10       Impact factor: 6.277

5.  Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer.

Authors:  Damien J Zanker; Alex J Spurling; Natasha K Brockwell; Katie L Owen; Jasmine M Zakhour; Tina Robinson; Hendrika M Duivenvoorden; Paul J Hertzog; Stefanie R Mullins; Robert W Wilkinson; Belinda S Parker
Journal:  Clin Transl Immunology       Date:  2020-09-28

6.  Colony-stimulating factor-1 (CSF-1) directly inhibits receptor activator of nuclear factor-{kappa}B ligand (RANKL) expression by osteoblasts.

Authors:  Y Wittrant; Y Gorin; S Mohan; B Wagner; S L Abboud-Werner
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

7.  Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways.

Authors:  Shuyu Guo; Yuanyuan Ni; Jingjing Ben; Yang Xia; Tingting Zhou; Dongyue Wang; Jieli Ni; Hui Bai; Lin Wang; Junqing Ma; Qi Chen
Journal:  Int J Biol Sci       Date:  2016-08-26       Impact factor: 6.580

8.  The inhibitory effect of melatonin on osteoclastogenesis of RAW 264.7 cells in low concentrations of RANKL and MCSF.

Authors:  Hala Jarrar; Damla Çetİn Altindal; Menemşe GÜmÜŞderelİoĞlu
Journal:  Turk J Biol       Date:  2020-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.